MedTrace Logo

Real-world Safety and Effectiveness Registry of Catheter Ablation of Paroxysmal Atrial Fibrillation as Initial Control Therapy With the Thermocool SmartTouch SF Catheter (A Sub-study of REAL AF Registry)

NCT07092774 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 344

Last updated 2025-10-31

No results posted yet for this study

Summary

To generate real-world evidence from the parent study, REAL AF registry, on the use of Thermocool SmartTouch SF (STSF) catheter in ablation for the treatment of paroxysmal atrial fibrillation (PAF).

Conditions

  • Paroxysmal Atrial Fibrillation (PAF)

Interventions

DEVICE

Ablation

Ablation procedure using the Thermocool Smarttouch SF

Sponsors & Collaborators

  • Biosense Webster, Inc.

    collaborator INDUSTRY

  • Heart Rhythm Clinical and Research Solutions, LLC

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2025-12-31
Completion
2025-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07092774 on ClinicalTrials.gov